Journal
VACCINE
Volume 25, Issue 10, Pages 1771-1779Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2006.11.019
Keywords
HBsAg-anti-HBs; dendritic cells; cytokines; chronic hepatitis B
Categories
Ask authors/readers for more resources
To study the responses of chronic hepatitis B patients to yeast-derived HBsAg-HBIG complexes (YIC) and the mechanisms involved, twenty HBeAg-positive chronic hepatitis B patients were immunized with 60 mu g of YIC or alum as the control at 4-week intervals, for 24 weeks. Five of ten patients responded to 60 mu g YIC immunization showing >= 2 logs decrease of serum HBV DNA with loss or marked reduction of HBeAg and appearance of anti-HBe; two of these patients developed anti-HBs. Flares of alanine aminotransferase were observed in 4 of the 5 responders, and in 2 out of 10 control patients. HBsAg-stimulated peripheral blood mononuclear cells (PBMCs) secreted Th1/Th2 cytokines around 24 weeks after immunization. Dendritic cells incubated with YIC showed the highest levels of IL-12 secretion and up-regulation of functional markers. Thus, the therapeutic effect of YIC is associated with cytolytic and non-cytolytic responses in patients. (c) 2006 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available